Effects of ruxolitinib cream on pruritus and sleep in atopic dermatitis: 52-week pooled results from two phase III studies

被引：0
|
作者：
Simpson, E. L. [1 ]
Boguniewicz, M. [2 ]
Thaci, D. [3 ]
Misery, L. [4 ]
Armstrong, A. W. [5 ]
Silverberg, J. I. [6 ]
Venturanza, M. E. [7 ]
Kallender, H. [7 ]
Gao, J. [7 ]
Szepietowski, J. C. [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Lubeck, Lubeck, Germany
[4] Univ Hosp Brest, Brest, France
[5] Univ Southern Calif, Los Angeles, CA 90007 USA
[6] George Washington Univ, Washington, DC USA
[7] Incyte Corp, Wilmington, DE USA
[8] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
675
引用
收藏
页码：E166 / E167
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Leung, Donald Y. M.
    Forman, Seth B.
    Venturanza, May E.
    Sun, Kang
    Kuligowski, Michael E.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 863 - 872
  • [42] Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial
    Zhao, Yan
    Zhang, Litao
    Wu, Liming
    Yang, Bin
    Wang, Jinyan
    Li, Yumei
    Li, Jingyi
    Diao, Qingchun
    Sun, Qing
    Zhu, Xiaohong
    Man, Xiaoyong
    Wang, Lihua
    Li, Linfeng
    Feng, Yanyan
    Zeng, Huiming
    Cai, Tao
    Ren, Hong
    Lu, Jianyun
    Lu, Qianjin
    Tao, Xiaohua
    Xiao, Rong
    Ji, Chao
    Li, Fuqiu
    Zhang, Jianzhong
    ALLERGY, 2024,
  • [43] Response to Papp et al's "Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies"
    Isaq, Nasro A.
    Link, Jenny L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : e19 - e20
  • [44] Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial
    Fuxench, Zelma C. Chiesa
    Lai, Zhihong
    Kuo, Yutzu
    Nawaz, Haq
    Cotliar, Jonathan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [45] Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)
    Wollenberg, A.
    Blauvelt, A.
    Guttman-Yassky, E.
    Worm, M.
    Lynde, C.
    Lacour, J. -P.
    Spelman, L.
    Katoh, N.
    Saeki, H.
    Poulin, Y.
    Lesiak, A.
    Kircik, L.
    Cho, S. H.
    Herranz, P.
    Cork, M. J.
    Peris, K.
    Steffensen, L. A.
    Bang, B.
    Kuznetsova, A.
    Jensen, T. N.
    osterdal, M. L.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : 437 - 449
  • [46] Effects of ruxolitinib cream on pruritus and quality of life in adult patients with atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study
    Kim, Brian S.
    Sofen, Howard L.
    Kuligowski, Michael E.
    Venturanza, May
    Sun, Kang
    Toth, Darryl
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB198 - AB198
  • [47] Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials
    Paller, Amy S.
    Yosipovitch, Gil
    Tom, Wynnis L.
    Lebwohl, Mark
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Tallman, Anna M.
    Tan, Bill
    Hebert, Adelaide A.
    PEDIATRICS, 2018, 142
  • [48] Effects of ruxolitinib cream on affected body areas in patients with vitiligo: Subgroup analysis from a 52-week, randomized, double-blind trial
    Grimes, Pearl
    Rosmarin, David
    Hamzavi, Iltefat
    Harris, John E.
    Lebwohl, Mark
    Gottlieb, Alice B.
    Butler, Kathleen A.
    Kuo, Fiona I.
    Sun, Kang
    Pandya, Amit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB197 - AB197
  • [49] Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials
    Paller, Amy S.
    Yosipovitch, Gil
    Tom, Wynnis L.
    Lebwohl, Mark
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Tallman, Anna M.
    Tan, Bill
    Hebert, Adelaide A.
    PEDIATRICS, 2018, 142
  • [50] Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2-11 years: 52 week results from a maximum-use trial
    Bissonnette, Robert
    Lee, Mark S.
    Forman, Seth B.
    Gold, Linda Stein
    Kallender, Howard
    Angel, Brett
    Kuo, Yutzu
    Paller, Amy S.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
12345